{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:34:54Z","timestamp":1759336494391},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10072-011-0633-1","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T07:25:14Z","timestamp":1306826714000},"page":"559-569","source":"Crossref","is-referenced-by-count":10,"title":["The concept of FDG-PET endophenotype in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"32","author":[{"given":"Emmanuel H.","family":"During","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. M.","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"issue":"3","key":"633_CR1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","volume":"3","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer R et al (2007) Forecasting the global burden of Alzheimer\u2019s disease. Alzheimers Dement 3(3):186\u2013191","journal-title":"Alzheimers Dement"},{"issue":"1","key":"633_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0306-4522(95)90397-P","volume":"64","author":"TG Ohm","year":"1995","unstructured":"Ohm TG et al (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer\u2019s disease-related neurofibrillary changes. Neuroscience 64(1):209\u2013217","journal-title":"Neuroscience"},{"issue":"4","key":"633_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259","journal-title":"Acta Neuropathol"},{"issue":"7","key":"633_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","volume":"140","author":"EB Larson","year":"2004","unstructured":"Larson EB et al (2004) Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 140(7):501\u2013509","journal-title":"Ann Intern Med"},{"issue":"2","key":"633_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.1986.tb04634.x","volume":"74","author":"PK M\u00f6ls\u00e4","year":"1986","unstructured":"M\u00f6ls\u00e4 PK, Marttila RJ, Rinne UK (1986) Survival and cause of death in Alzheimer\u2019s disease and multi-infarct dementia. Acta Neurol Scand 74(2):103\u2013107","journal-title":"Acta Neurol Scand"},{"key":"633_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1196\/annals.1379.011","volume":"1097","author":"EM Reiman","year":"2007","unstructured":"Reiman EM (2007) Linking brain imaging and genomics in the study of Alzheimer\u2019s disease and aging. Ann N Y Acad Sci 1097:94\u2013113","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"633_CR7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.tig.2006.04.004","volume":"22","author":"CE Bearden","year":"2006","unstructured":"Bearden CE, Freimer NB (2006) Endophenotypes for psychiatric disorders: ready for primetime? Trends Genet 22(6):306\u2013313","journal-title":"Trends Genet"},{"issue":"3","key":"633_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0166-2236(97)01187-9","volume":"21","author":"M Leboyer","year":"1998","unstructured":"Leboyer M et al (1998) Psychiatric genetics: search for phenotypes. Trends Neurosci 21(3):102\u2013105","journal-title":"Trends Neurosci"},{"issue":"3","key":"633_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0891988706291088","volume":"19","author":"T Sunderland","year":"2006","unstructured":"Sunderland T et al (2006) Biomarkers in the diagnosis of Alzheimer\u2019s disease: are we ready? J Geriatr Psychiatry Neurol 19(3):172\u2013179","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3723","key":"633_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.152.3723.711","volume":"152","author":"B John","year":"1966","unstructured":"John B, Lewis KR (1966) Chromosome variability and geographic distribution in insects. Science 152(3723):711\u2013721","journal-title":"Science"},{"issue":"566","key":"633_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1192\/bjp.122.1.15","volume":"122","author":"II Gottesman","year":"1973","unstructured":"Gottesman II, Shields J (1973) Genetic theorizing and schizophrenia. Br J Psychiatry 122(566):15\u201330","journal-title":"Br J Psychiatry"},{"issue":"4","key":"633_CR12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1176\/appi.ajp.160.4.636","volume":"160","author":"II Gottesman","year":"2003","unstructured":"Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160(4):636\u2013645","journal-title":"Am J Psychiatry"},{"issue":"2","key":"633_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biopsych.2005.11.006","volume":"60","author":"G Hasler","year":"2006","unstructured":"Hasler G et al (2006) Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 60(2):93\u2013105","journal-title":"Biol Psychiatry"},{"issue":"10","key":"633_CR14","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1176\/appi.ajp.157.10.1660","volume":"157","author":"KS Cadenhead","year":"2000","unstructured":"Cadenhead KS et al (2000) Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry 157(10):1660\u20131668","journal-title":"Am J Psychiatry"},{"key":"633_CR15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"D Braff","year":"2001","unstructured":"Braff D, Geyer M, Swerdlow N (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234\u2013258","journal-title":"Psychopharmacology"},{"key":"633_CR16","first-page":"703","volume-title":"Neuropsychopharamcology: the fifth generation of progress","author":"D Braff","year":"2002","unstructured":"Braff D, Freedman R (2002) Endophenotypes in studies of the genetics of schizophrenia. In: Davis K et al (eds) Neuropsychopharamcology: the fifth generation of progress, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 703\u2013716","edition":"5"},{"key":"633_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/31.3.451","volume":"31","author":"A Diefendorf","year":"1908","unstructured":"Diefendorf A, Dodge R (1908) An experimental study of the ocular reactions of the insane from photographic records. Brain 31:451\u2013489","journal-title":"Brain"},{"issue":"Suppl","key":"633_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1440-1614.2000.00781.x","volume":"34","author":"K Lee","year":"2000","unstructured":"Lee K, Williams L (2000) Eye movement dysfunction as a biological marker of risk for schizophrenia. Aust N Z J 34(Suppl):91\u2013100","journal-title":"Aust N Z J"},{"key":"633_CR19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1073\/pnas.94.2.587","volume":"94","author":"R Freedman","year":"1997","unstructured":"Freedman R et al (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587\u2013592","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"633_CR20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/(SICI)1096-8628(19961122)67:6<564::AID-AJMG10>3.0.CO;2-R","volume":"67","author":"V Arolt","year":"1996","unstructured":"Arolt V et al (1996) Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet 67(6):564\u2013579","journal-title":"Am J Med Genet"},{"issue":"1","key":"633_CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.b.10757","volume":"116B","author":"TL Gasperoni","year":"2003","unstructured":"Gasperoni TL et al (2003) Genetic linkage and association between chromosome 1q and working memory function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 116B(1):8\u201316","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"4","key":"633_CR22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1176\/appi.ajp.160.4.709","volume":"160","author":"JH Callicott","year":"2003","unstructured":"Callicott JH et al (2003) Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160(4):709\u2013719","journal-title":"Am J Psychiatry"},{"issue":"5123","key":"633_CR23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261(5123):921\u2013923","journal-title":"Science"},{"issue":"8873","key":"633_CR24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","volume":"342","author":"J Poirier","year":"1993","unstructured":"Poirier J et al (1993) Apolipoprotein E polymorphism and Alzheimer\u2019s disease. Lancet 342(8873):697\u2013699","journal-title":"Lancet"},{"issue":"4","key":"633_CR25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.GIM.0000132679.92238.58","volume":"6","author":"LA Cupples","year":"2004","unstructured":"Cupples LA et al (2004) Estimating risk curves for first-degree relatives of patients with Alzheimer\u2019s disease: the REVEAL study. Genet Med. 6(4):192\u2013196","journal-title":"Genet Med."},{"issue":"10","key":"633_CR26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2008.07.004","volume":"64","author":"CS Bloss","year":"2008","unstructured":"Bloss CS et al (2008) Decreased cognition in children with risk factors for Alzheimer\u2019s disease. Biol Psychiatry 64(10):904\u2013906","journal-title":"Biol Psychiatry"},{"issue":"6","key":"633_CR27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.neurobiolaging.2006.12.019","volume":"29","author":"NV Ponomareva","year":"2008","unstructured":"Ponomareva NV, Korovaitseva GI, Rogaev EI (2008) EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol Aging 29(6):819\u2013827","journal-title":"Neurobiol Aging"},{"key":"633_CR28","first-page":"263","volume":"24","author":"SG Younkin","year":"1998","unstructured":"Younkin SG et al (1998) Genetic elevation of plasma amyloid \u00df protein in typical late onset Alzheimer\u2019s disease. Abstr Soc Neurosci 24:263","journal-title":"Abstr Soc Neurosci"},{"issue":"9","key":"633_CR29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","volume":"56","author":"T Sunderland","year":"2004","unstructured":"Sunderland T et al (2004) Cerebrospinal fluid beta-amyloid1\u201342 and tau in control subjects at risk for Alzheimer\u2019s disease: the effect of APOE epsilon4 allele. Biol Psychiatry 56(9):670\u2013676","journal-title":"Biol Psychiatry"},{"issue":"2","key":"633_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0b013e3181c918cb","volume":"74","author":"RA Honea","year":"2010","unstructured":"Honea RA et al (2010) Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 74(2):113\u2013120","journal-title":"Neurology"},{"issue":"3","key":"633_CR31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55(3):306\u2013319","journal-title":"Ann Neurol"},{"issue":"16","key":"633_CR32","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman EM et al (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci USA 106(16):6820\u20136825","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"633_CR33","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1073\/pnas.0914141107","volume":"107","author":"L Mosconi","year":"2010","unstructured":"Mosconi L et al (2010) Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer\u2019s. Proc Natl Acad Sci USA 107(13):5949\u20135954","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"633_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/jcbfm.1983.57","volume":"3","author":"MJ Leon de","year":"1983","unstructured":"de Leon MJ et al (1983) Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer\u2019s disease. J Cereb Blood Flow Metab 3(3):391\u2013394","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5401","key":"633_CR35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1126\/science.283.5401.496","volume":"283","author":"P Magistretti","year":"1999","unstructured":"Magistretti P et al (1999) Energy on demand. Science 283(5401):496\u2013497","journal-title":"Science"},{"issue":"3","key":"633_CR36","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.neuroimage.2003.07.002","volume":"20","author":"AB Rocher","year":"2003","unstructured":"Rocher AB et al (2003) Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage 20(3):1894\u20131898","journal-title":"Neuroimage"},{"issue":"19","key":"633_CR37","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","volume":"98","author":"MJ Leon de","year":"2001","unstructured":"de Leon MJ et al (2001) Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-d-glucose\/positron-emission tomography (FDG\/PET). Proc Natl Acad Sci USA 98(19):10966\u201310971","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"633_CR38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-4580(01)00230-5","volume":"22","author":"S Santi De","year":"2001","unstructured":"De Santi S et al (2001) Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 22(4):529\u2013539","journal-title":"Neurobiol Aging"},{"issue":"5","key":"633_CR39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","volume":"29","author":"L Mosconi","year":"2008","unstructured":"Mosconi L et al (2008) Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 29(5):676\u2013692","journal-title":"Neurobiol Aging"},{"issue":"1","key":"633_CR40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/nimg.2002.1208","volume":"17","author":"K Herholz","year":"2002","unstructured":"Herholz K et al (2002) Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17(1):302\u2013316","journal-title":"Neuroimage"},{"issue":"5","key":"633_CR41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.159.5.738","volume":"159","author":"GE Alexander","year":"2002","unstructured":"Alexander GE et al (2002) Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer\u2019s disease treatment studies. Am J Psychiatry 159(5):738\u2013745","journal-title":"Am J Psychiatry"},{"issue":"4","key":"633_CR42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med. Mol Imaging 32(4):486\u2013510","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"633_CR43","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","volume":"35","author":"Y Li","year":"2008","unstructured":"Li Y et al (2008) Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 35(12):2169\u20132181","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"633_CR44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/S1041610207006394","volume":"20","author":"B Reisberg","year":"2008","unstructured":"Reisberg B et al (2008) Mild cognitive impairment (MCI): a historical perspective. Int Psychogeriatr 20(1):18\u201331","journal-title":"Int Psychogeriatr"},{"issue":"9518","key":"633_CR45","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","volume":"367","author":"S Gauthier","year":"2006","unstructured":"Gauthier S et al (2006) Mild cognitive impairment. Lancet 367(9518):1262\u20131270","journal-title":"Lancet"},{"issue":"3","key":"633_CR46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.10669","volume":"54","author":"PJ Nestor","year":"2003","unstructured":"Nestor PJ et al (2003) Limbic hypometabolism in Alzheimer\u2019s disease and mild cognitive impairment. Ann Neurol 54(3):343\u2013351","journal-title":"Ann Neurol"},{"issue":"11","key":"633_CR47","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","volume":"64","author":"L Mosconi","year":"2005","unstructured":"Mosconi L et al (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64(11):1860\u20131867","journal-title":"Neurology"},{"issue":"2","key":"633_CR48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00259-005-1956-z","volume":"33","author":"L Mosconi","year":"2006","unstructured":"Mosconi L et al (2006) Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer\u2019s disease using FDG-PET. Eur J Nucl Med Mol Imaging 33(2):210\u2013221","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"633_CR49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S et al (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease. Ann Neurol 42(1):85\u201394","journal-title":"Ann Neurol"},{"issue":"8","key":"633_CR50","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","volume":"30","author":"A Drzezga","year":"2003","unstructured":"Drzezga A et al (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30(8):1104\u20131113","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"633_CR51","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","volume":"63","author":"L Mosconi","year":"2004","unstructured":"Mosconi L et al (2004) MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 63(12):2332\u20132340","journal-title":"Neurology"},{"issue":"10","key":"633_CR52","first-page":"1625","volume":"46","author":"A Drzezga","year":"2005","unstructured":"Drzezga A et al (2005) Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med 46(10):1625\u20131632","journal-title":"J Nucl Med"},{"issue":"8","key":"633_CR53","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","volume":"60","author":"G Ch\u00e9telat","year":"2003","unstructured":"Ch\u00e9telat G et al (2003) Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer\u2019s disease? Neurology 60(8):1374\u20131377","journal-title":"Neurology"},{"issue":"1","key":"633_CR54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/bmm.09.91","volume":"4","author":"EM Reiman","year":"2010","unstructured":"Reiman EM, Langbaum JBS, Tariot PN (2010) Alzheimer\u2019s prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med 4(1):3\u201314","journal-title":"Biomark Med"},{"issue":"3","key":"633_CR55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0891988706291089","volume":"19","author":"GW Small","year":"2006","unstructured":"Small GW (2006) Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease. J Geriatr Psychiatry Neurol 19(3):180\u2013185","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"12","key":"633_CR56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","volume":"334","author":"EM Reiman","year":"1996","unstructured":"Reiman EM et al (1996) Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334(12):752\u2013758","journal-title":"N Engl J Med"},{"issue":"11","key":"633_CR57","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.090106797","volume":"97","author":"GW Small","year":"2000","unstructured":"Small GW et al (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci USA 97(11):6037\u20136042","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"633_CR58","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","volume":"98","author":"EM Reiman","year":"2001","unstructured":"Reiman EM et al (2001) Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer\u2019s disease. Proc Natl Acad Sci USA 98(6):3334\u20133339","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"633_CR59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"EM Reiman","year":"2004","unstructured":"Reiman EM et al (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia. Proc Natl Acad Sci USA 101(1):284\u2013289","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"633_CR60","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","volume":"102","author":"EM Reiman","year":"2005","unstructured":"Reiman EM et al (2005) Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA 102(23):8299\u20138302","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"633_CR61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JAD-2008-13203","volume":"13","author":"M Rimajova","year":"2008","unstructured":"Rimajova M et al (2008) Fluoro-2-deoxy-d-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population. J Alzheimers Dis 13(2):137\u2013146","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"633_CR62","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.biopsych.2007.05.030","volume":"63","author":"L Mosconi","year":"2008","unstructured":"Mosconi L et al (2008) Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry 63(6):609\u2013618","journal-title":"Biol Psychiatry"},{"issue":"12","key":"633_CR63","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jama.273.12.942","volume":"273","author":"GW Small","year":"1995","unstructured":"Small GW et al (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273(12):942\u2013947","journal-title":"JAMA"},{"issue":"48","key":"633_CR64","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1073\/pnas.0705036104","volume":"104","author":"L Mosconi","year":"2007","unstructured":"Mosconi L et al (2007) Maternal family history of Alzheimer\u2019s disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA 104(48):9067\u20139072","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"633_CR65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/01.wnl.0000333247.51383.43","volume":"72","author":"L Mosconi","year":"2009","unstructured":"Mosconi L et al (2009) Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology 72(6):513\u2013520","journal-title":"Neurology"},{"issue":"2","key":"633_CR66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M et al (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63(2):168\u2013174","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"633_CR67","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2003.12.023","volume":"25","author":"J Raber","year":"2004","unstructured":"Raber J, Huang Y, Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25(5):641\u2013650","journal-title":"Neurobiol Aging"},{"issue":"8","key":"633_CR68","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43(8):1467\u20131472","journal-title":"Neurology"},{"issue":"12","key":"633_CR69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0166-2236(94)90156-2","volume":"17","author":"J Poirier","year":"1994","unstructured":"Poirier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer\u2019s disease. Trends Neurosci 17(12):525\u2013530","journal-title":"Trends Neurosci"},{"issue":"6","key":"633_CR70","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM et al (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 97(6):2892\u20132897","journal-title":"Proc Natl Acad Sci USA"},{"key":"633_CR71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD et al (2007) Transport pathways for clearance of human Alzheimer\u2019s amyloid betapeptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27:909\u2013918","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"633_CR72","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/brain\/awn254","volume":"132","author":"G Xu","year":"2008","unstructured":"Xu G et al (2008) The influence of parental history of Alzheimer\u2019s disease and apolipoprotein E 4 on the BOLD signal during recognition memory. Brain 132(2):383\u2013391","journal-title":"Brain"},{"issue":"7","key":"633_CR73","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM200008173430701","volume":"343","author":"SY Bookheimer","year":"2000","unstructured":"Bookheimer SY et al (2000) Patterns of brain activation in people at risk for Alzheimer\u2019s disease. N Engl J Med 343(7):450\u2013456","journal-title":"N Engl J Med"},{"issue":"11","key":"633_CR74","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1212\/01.WNL.0000128088.08695.05","volume":"62","author":"JA Prince","year":"2004","unstructured":"Prince JA et al (2004) APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 62(11):2116\u20132118","journal-title":"Neurology"},{"issue":"1","key":"633_CR75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC et al (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67(1):122\u2013131","journal-title":"Ann Neurol"},{"issue":"3","key":"633_CR76","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-4-3-170","volume":"4","author":"L Mosconi","year":"2010","unstructured":"Mosconi L et al (2010) Maternal transmission of Alzheimer\u2019s disease: prodromal metabolic phenotype and the search for genes. Hum Genomics 4(3):170\u2013193","journal-title":"Hum Genomics"},{"issue":"1","key":"633_CR77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/WNL.47.1.254","volume":"47","author":"SD Edland","year":"1996","unstructured":"Edland SD et al (1996) Increased risk of dementia in mothers of Alzheimer\u2019s disease cases: evidence for maternal inheritance. Neurology 47(1):254\u2013256","journal-title":"Neurology"},{"issue":"12","key":"633_CR78","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/archneur.64.12.1743","volume":"64","author":"E G\u00f3mez-Tortosa","year":"2007","unstructured":"G\u00f3mez-Tortosa E et al (2007) Variability of age at onset in siblings with familial Alzheimer disease. Arch Neurol 64(12):1743\u20131748","journal-title":"Arch Neurol"},{"issue":"8","key":"633_CR79","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.40.8.1302","volume":"40","author":"WD Parker","year":"1990","unstructured":"Parker WD, Filley CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer\u2019s disease. Neurology 40(8):1302\u20131303","journal-title":"Neurology"},{"issue":"Suppl 2","key":"633_CR80","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","volume":"20","author":"RH Swerdlow","year":"2010","unstructured":"Swerdlow RH, Burns JM, Khan SM (2010) The Alzheimer\u2019s disease mitochondrial cascade hypothesis. J Alzheimers Dis 20(Suppl 2):S265\u2013S279","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"633_CR81","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1471-4159.2004.02438.x","volume":"89","author":"SM Cardoso","year":"2004","unstructured":"Cardoso SM et al (2004) Mitochondria dysfunction of Alzheimer\u2019s disease cybrids enhances Abeta toxicity. J Neurochem 89(6):1417\u20131426","journal-title":"J Neurochem"},{"issue":"4","key":"633_CR82","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/157340006778699729","volume":"2","author":"Y Chen","year":"2006","unstructured":"Chen Y, Bidwell LC, Norton D (2006) Trait vs. state markers for schizophrenia: identification and characterization through visual processes. Curr Psychiatry Rev 2(4):431\u2013438","journal-title":"Curr Psychiatry Rev"},{"issue":"4","key":"633_CR83","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.20799","volume":"59","author":"W Jagust","year":"2006","unstructured":"Jagust W et al (2006) Brain imaging evidence of preclinical Alzheimer\u2019s disease in normal aging. Ann Neurol 59(4):673\u2013681","journal-title":"Ann Neurol"},{"issue":"5","key":"633_CR84","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi L et al (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 36(5):811\u2013822","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"14","key":"633_CR85","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T G\u00f3mez-Isla","year":"1996","unstructured":"G\u00f3mez-Isla T et al (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease. J Neurosci 16(14):4491\u20134500","journal-title":"J Neurosci"},{"issue":"6","key":"633_CR86","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3174\/ajnr.A1059","volume":"29","author":"AM Fjell","year":"2008","unstructured":"Fjell AM et al (2008) Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment. Am J Neuroradiol 29(6):1183\u20131189","journal-title":"Am J Neuroradiol"},{"issue":"Pt 5","key":"633_CR87","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","volume":"132","author":"CR Jack","year":"2009","unstructured":"Jack CR et al (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: implications for sequence of pathological events in Alzheimer\u2019s disease. Brain 132(Pt 5):1355\u20131365","journal-title":"Brain"},{"issue":"6","key":"633_CR88","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1523\/JNEUROSCI.5062-08.2009","volume":"29","author":"RL Buckner","year":"2009","unstructured":"Buckner RL et al (2009) Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer\u2019s disease. J Neurosci 29(6):1860\u20131873","journal-title":"J Neurosci"},{"issue":"2","key":"633_CR89","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1073\/pnas.98.2.676","volume":"98","author":"ME Raichle","year":"2001","unstructured":"Raichle ME et al (2001) A default mode of brain function. Proc Natl Acad Sci USA 98(2):676\u2013682","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"633_CR90","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tig.2009.12.004","volume":"26","author":"K Sleegers","year":"2010","unstructured":"Sleegers K et al (2010) The pursuit of susceptibility genes for Alzheimer\u2019s disease: progress and prospects. Trends Genet 26(2):84\u201393","journal-title":"Trends Genet"},{"key":"633_CR91","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hbm.20401","volume":"28","author":"DC Glahn","year":"2007","unstructured":"Glahn DC, Thompson PM, Blangero J (2007) Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Hum Brain Mapp 28:488\u2013501","journal-title":"Hum Brain Mapp"},{"key":"633_CR92","doi-asserted-by":"crossref","unstructured":"Jun G. et al. (2010) Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes. Arch Neurol (ahead of print)","DOI":"10.1001\/archneurol.2010.201"},{"issue":"3","key":"633_CR93","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jalz.2010.03.013","volume":"6","author":"AJ Saykin","year":"2010","unstructured":"Saykin AJ et al (2010) Alzheimer\u2019s disease neuroimaging initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans. Alzheimer\u2019s Dement 6(3):265\u2013273","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"633_CR94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7(2):180\u2013184","journal-title":"Nat Genet"},{"issue":"1\u20132","key":"633_CR95","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0304-3940(94)91074-X","volume":"175","author":"HL West","year":"1994","unstructured":"West HL, Rebeck GW, Hyman BT (1994) Frequency of the apolipoprotein E [epsilon] 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 175(1\u20132):46\u201348","journal-title":"Neurosci Lett"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0633-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-011-0633-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0633-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T05:28:48Z","timestamp":1560230928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-011-0633-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1007\/s10072-011-0633-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}